THERAVANCE INC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THERAVANCE INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THERAVANCE INC. THERAVANCE INC is 10% Owner in Armata Pharmaceuticals, Inc. ($APHB) and Director in Armata Pharmaceuticals, Inc. ($APHB) and 10% Owner in Innoviva, Inc. ($THRX) and Director in Innoviva, Inc. ($THRX) and 10% Owner in Theravance Biopharma, Inc. ($TBPH) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX).
Latest Insider Trading Transactions of THERAVANCE INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APHB, ETTX, THRX, TBPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.00 | 6,268,975 | 12,537,950 | 10,000,000 | |
Jun 11 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.00 | 6,268,975 | 12,537,950 | 10,000,000 | 3.7 M to 10 M (+168.02 %) |
Mar 17 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | |
Mar 17 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Buy | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | 1.9 M to 6.2 M (+229.45 %) |
Mar 17 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | |
Mar 17 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Buy | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | 1.9 M to 6.2 M (+229.45 %) |
Jan 28 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | |
Jan 28 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Buy | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | 0 to 1.9 M |
Jan 28 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | |
Jan 28 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Buy | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | 0 to 1.9 M |
Jan 28 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | |
Jan 28 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Buy | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 | 0 to 1.9 M |
Sep 01 2020 | ETTX | Entasis Therapeuti ... | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.68 | 4,672,897 | 12,499,999 | 18,672,897 | |
Sep 01 2020 | ETTX | Entasis Therapeuti ... | Innoviva, Inc. | 10% Owner | Buy | P | 2.68 | 4,672,897 | 12,499,999 | 18,672,897 | 14 M to 18.7 M (+33.38 %) |
Sep 01 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.68 | 4,672,897 | 12,499,999 | 18,672,897 | |
Sep 01 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.68 | 4,672,897 | 12,499,999 | 18,672,897 | 14 M to 18.7 M (+33.38 %) |
Jun 12 2020 | ETTX | Entasis Therapeuti ... | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.50 | 12,677,490 | 31,693,725 | 14,000,000 | |
Jun 12 2020 | ETTX | Entasis Therapeuti ... | Innoviva, Inc. | 10% Owner | Buy | P | 2.50 | 12,677,490 | 31,693,725 | 14,000,000 | 1.3 M to 14 M (+958.59 %) |
Jun 12 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.50 | 12,677,490 | 31,693,725 | 14,000,000 | |
Jun 12 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.50 | 12,677,490 | 31,693,725 | 14,000,000 | 1.3 M to 14 M (+958.59 %) |
Mar 31 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | |
Mar 31 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | 993.1 K to 8.7 M (+777.10 %) |
Mar 31 2020 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | |
Mar 31 2020 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | 10% Owner | Buy | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | 993.1 K to 8.7 M (+777.10 %) |
Mar 31 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | |
Mar 31 2020 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | 993.1 K to 8.7 M (+777.10 %) |
Mar 31 2020 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | |
Mar 31 2020 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | 10% Owner | Buy | P | 2.87 | 7,717,661 | 22,149,687 | 8,710,800 | 993.1 K to 8.7 M (+777.10 %) |
May 19 2014 | TBPH | Theravance Biophar ... | THERAVANCE INC | 10% Owner | Sell | J | 0.00 | 33,100,000 | 0 | 0 | 33.1 M to 0 (-100.00 %) |
May 19 2014 | THRX | Innoviva, Inc. | THERAVANCE INC | 10% Owner | Sell | J | 0.00 | 33,100,000 | 0 | 0 | 33.1 M to 0 (-100.00 %) |
Page: 1